AI boosts life sciences ROI by accelerating drug discovery, reducing R&D costs, optimizing clinical trials and enabling precision medicine through strategic tech partnerships.Dublin, Sept. 30, 2026 ...

AI is accelerating drug discovery, with lead optimization and oncology leading adoption. Pharma-biotech partnerships, funding and precision medicine offer key opportunities.Dublin, Sept. (GLOBE ...

The Russian startup Ligand Pro, founded by experts from Skoltech, presented a platform for the development of drug molecules ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates never reaching the market. Today, artificial intelligence methods have ...

MIT engineers have found a way to stabilize the lipid nanoparticles used to deliver RNA vaccines, which could allow the vaccines to be more widely distributed.

The latest company to spin out of a Stanford Medicine lab is a biotech undertaking with 37,000 employees—and none of them are ...

This Collection supports and amplifies research related to SDG 5: Gender Equality. Living systems are inherently complex, exhibiting self-organizing and emergent behaviors arising from dynamic ...

AI-driven drug discovery can be accelerated by combining cell-free expression with purification-free SPR for faster ...

Artificial intelligence is transforming chemistry from analyzing molecules to designing them with unprecedented precision. Join three leading researchers as they explore how AI, molecular simulations, ...

China is seeing a fresh fundraising boom for artificial intelligence-powered drug developers, with start-ups including a ByteDance spin-off raising hundreds of millions of dollars this week as ...